Exposure was defined according to maternal year of birth and HPV immunisation eligibility: pre-immunisation cohort (1986–1990), catch-up immunisation cohort (1991–1994) and routine immunisation cohort (1995–1996). Outcomes were defined as spontaneous preterm birth (PTB), low birth weight (LBW)...
through 1 month after the 3rd dose (per-protocol population; vaccine n = 7,811; placebo n = 7,785), the vaccine was 100 % effective (95 % CI: 72 to 100) against VIN2-3 or VaIN2-3 associated with HPV16 or HPV18. In the intention-to-treat population (which included 18,174 women...
HPV vaccination knowledge varied also between 6.2 and 90.6% in parents, being highest in the UK and lowest in the Netherlands studies; and between 10.1 and 87.1% in adolescents, being highest in Belgium and lowest in Latvia (Fig. 2). Fig. 2 Percentage of HPV and vaccine knowledge per ...
Human Papillomavirus (HPV) vaccine was recently introduced into routine immunization in Nigeria, beginning with 15 States in the first phase. This study was carried out among 1012 parents/caregivers of adolescent girls who received the vaccine during the 5 days of the HPV immunization campaign in O...
Most of the high-grade disease observed in the UK in non-immunised women has been driven by HPV 16 and 18 (Mesher et al, 2015). HPV 16 particularly is known to have a shorter natural history in the development of CIN3. Lesions related to non-vaccine types may be detected at an ...
The quadrivalent human papillomavirus (HPV) vaccine has been assumed to give protection against genital warts (GW) as well as cervical cancer. Our main question was whether HPV vaccine has any effects on the prevention of GW reported in randomised contro
Eligibility criteria Quantitative, qualitative, and mixed-methods studies were eligible for inclusion if they reported the factors (barriers to and/or facilitators of) affecting HPV vaccine uptake, and/or initiation or completion of HPV vaccination series among ethnic minority adolescent girls. Consistent...
Does the HPV vaccination programme have implications for cervical screening programmes in the UK? Vaccine. 2014;32:1828–33. Article PubMed PubMed Central Google Scholar Bernard E, Saint-Lary O, Haboubi L, Le Breton J. Dépistage du cancer du col de l’utérus : connaissances et ...
Your primary care doctor, gynaecologist, or local health clinic are common places to receive the HPV vaccine. You may qualify for a free vaccine, but eligibility varies from country to country. In the UK, for example, you can get vaccinated for free if you are: ...
7Department of Cytology, Ninewells Hospital, Dundee DD1 9SY, Scotland and 8International Prevention Research Institute, Lyon, France Background: To measure the uptake of first invitation to cervical screening by vaccine status in a population-based cohort offered HPV immunisation in a national catch-...